Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 5821 AL 5835

Case Study 3: A 58-Year-Old Woman Referred for Evaluation of Suspected Alzheimer Dementia

Maneval J, Woods JK, Feany MB, Miller MB, Silbersweig DA, Gale SA, Daffner KR, McGinnis SM.

J Neuropsychiatry Clin Neurosci. 2022 Fall;34(4):307-315. doi: 10.1176/appi.neuropsych.20220113.

Challenges in diagnosis and management of delirium in Lewy body disease

Richardson S, Lawson RA, Price A, Taylor JP.

Acta Psychiatr Scand. 2023 May;147(5):475-480. doi: 10.1111/acps.13514. Epub 2022 Nov 4.

Imaging Biomarkers for Central Nervous System Drug Development and Future Clinical Utility: Lessons from Neurodegenerative Disorders

Seibyl JP.

J Nucl Med. 2023 Jan;64(1):12-19. doi: 10.2967/jnumed.122.264773. Epub 2022 Oct 27.

Recent Advances in the Roles of MicroRNA and MicroRNA-Based Diagnosis in Neurodegenerative Diseases

Zhang J, Chen Z, Chen H, Deng Y, Li S, Jin L.

Biosensors (Basel). 2022 Nov 24;12(12):1074. doi: 10.3390/bios12121074.

[The role of hyperuricemia in the development of cognitive changes in the elderly.]

Kunitskaya NA, Ariev AL.

Adv Gerontol. 2022;35(5):775-782.

Could VGF and/or its derived peptide act as biomarkers for the diagnosis of neurodegenerative diseases: A systematic review

Alqarni S, Alsebai M.

Front Endocrinol (Lausanne). 2022 Dec 22;13:1032192. doi: 10.3389/fendo.2022.1032192. eCollection 2022.

Epilepsy in Early Onset Alzheimer's Disease

Haoudy S, Jonveaux T, Puisieux S, Epstein J, Hopes L, Maillard L, Aron O, Tyvaert L.

J Alzheimers Dis. 2022;85(2):615-626. doi: 10.3233/JAD-210681.

Towards Defining the Neuroanatomical Basis of Late-Onset Psychiatric Symptoms

Barker MS, Cosentino SA, Fremont R, Devanand DP, Huey ED.

J Geriatr Psychiatry Neurol. 2022 Nov;35(6):751-762. doi: 10.1177/08919887221090213. Epub 2022 Apr 5.

The Key Role of Magnetic Resonance Imaging in the Detection of Neurodegenerative Diseases-Associated Biomarkers: A Review

Li KR, Wu AG, Tang Y, He XP, Yu CL, Wu JM, Hu GQ, Yu L.

Mol Neurobiol. 2022 Oct;59(10):5935-5954. doi: 10.1007/s12035-022-02944-x. Epub 2022 Jul 12.

Exosomal microRNAs as diagnostic biomarkers and therapeutic applications in neurodegenerative diseases

Sataer X, Qifeng Z, Yingying Z, Chunhua H, Bingzhenga F, Zhiran X, Wanli L, Yuwei Y, Shuangfeng C, Lingling W, Hongri H, Jibing C, Xiaoping R, Hongjun G.

Neurol Res. 2023 Mar;45(3):191-199. doi: 10.1080/01616412.2022.2129768. Epub 2022 Oct 2.

Measurement properties of outcome measures used in neurological telerehabilitation: A systematic review using COSMIN checklist

Brito SAF, Scianni AA, Peniche PDC, Faria CDCM.

Clin Rehabil. 2023 Mar;37(3):415-435. doi: 10.1177/02692155221129834. Epub 2022 Nov 29.

Extracellular vesicles, from the pathogenesis to the therapy of neurodegenerative diseases

Xia X, Wang Y, Zheng JC.

Transl Neurodegener. 2022 Dec 12;11(1):53. doi: 10.1186/s40035-022-00330-0.

Recent research advances in young-onset dementia

Loi SM, Pijnenburg Y, Velakoulis D.

Curr Opin Psychiatry. 2023 Mar 1;36(2):126-133. doi: 10.1097/YCO.0000000000000843. Epub 2022 Dec 28.

Fractal dimension of the brain in neurodegenerative disease and dementia: A systematic review

Ziukelis ET, Mak E, Dounavi ME, Su L, T O'Brien J.

Ageing Res Rev. 2022 Aug;79:101651. doi: 10.1016/j.arr.2022.101651. Epub 2022 May 25.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias